Bleakley Financial Group »

Nrx Pharmaceuticals shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of Nrx Pharmaceuticals (NRXP) shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in Nrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Nrx Pharmaceuticals held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nrx Pharmaceuticals by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $318k 117k 2.71

More positions owned by Bleakley Financial Group

Ishares Tr Core S&p500 Etf (IVV)
Sprott Asset Management Physical Gold An (CEF)
Apple (AAPL)
Vanguard Index Fds Large Cap Etf (VV)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p Scp Etf (IJR)
Microsoft Corporation (MSFT)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Core S&p Mcp Etf (IJH)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Global X Fds 1-3 Month T-bill (CLIP)
Vanguard Index Fds Growth Etf (VUG)
Amazon (AMZN)
Ishares Core Msci Emkt (IEMG)

View all positions for Bleakley Financial Group

Top funds holding Nrx Pharmaceuticals

Frigate Ventures
Vanguard Group
Commonwealth Equity Services
AdvisorShares Investments
Geode Capital Management
Bleakley Financial Group
State Street Corporation
BlackRock
Jane Street
Two Sigma Investments
Global Retirement Partners
One Wealth Management Investment & Advisory Services
Chicago Partners Investment
Citadel Advisors
Northern Trust

View all funds holding Nrx Pharmaceuticals